Literature DB >> 25888573

Respiratory protease/antiprotease balance determines susceptibility to viral infection and can be modified by nutritional antioxidants.

Megan Meyer1, Ilona Jaspers2.   

Abstract

The respiratory epithelium functions as a central orchestrator to initiate and organize responses to inhaled stimuli. Proteases and antiproteases are secreted from the respiratory epithelium and are involved in respiratory homeostasis. Modifications to the protease/antiprotease balance can lead to the development of lung diseases such as emphysema or chronic obstructive pulmonary disease. Furthermore, altered protease/antiprotease balance, in favor for increased protease activity, is associated with increased susceptibility to respiratory viral infections such as influenza virus. However, nutritional antioxidants induce antiprotease expression/secretion and decrease protease expression/activity, to protect against viral infection. As such, this review will elucidate the impact of this balance in the context of respiratory viral infection and lung disease, to further highlight the role epithelial cell-derived proteases and antiproteases contribute to respiratory immune function. Furthermore, this review will offer the use of nutritional antioxidants as possible therapeutics to boost respiratory mucosal responses and/or protect against infection.
Copyright © 2015 the American Physiological Society.

Entities:  

Keywords:  nutritional antioxidants; protease/antiprotease; viral infection

Mesh:

Substances:

Year:  2015        PMID: 25888573      PMCID: PMC4587599          DOI: 10.1152/ajplung.00028.2015

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  194 in total

Review 1.  Respiratory epithelial cells in innate immunity to influenza virus infection.

Authors:  Catherine J Sanders; Peter C Doherty; Paul G Thomas
Journal:  Cell Tissue Res       Date:  2010-09-17       Impact factor: 5.249

2.  Human immunodeficiency virus type 1 stimulates the expression and production of secretory leukocyte protease inhibitor (SLPI) in oral epithelial cells: a role for SLPI in innate mucosal immunity.

Authors:  N K Jana; L R Gray; D C Shugars
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

3.  Human bronchial epithelial cells express and secrete MMP-12.

Authors:  Mark C Lavigne; Paresh Thakker; Jason Gunn; Anthony Wong; Joy S Miyashiro; Aeona M Wasserman; Shui-Qing Wei; Jeffrey W Pelker; Michiko Kobayashi; Michael J Eppihimer
Journal:  Biochem Biophys Res Commun       Date:  2004-11-12       Impact factor: 3.575

4.  Secretory leukocyte protease inhibitor: a human saliva protein exhibiting anti-human immunodeficiency virus 1 activity in vitro.

Authors:  T B McNeely; M Dealy; D J Dripps; J M Orenstein; S P Eisenberg; S M Wahl
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

5.  Interrelationships between the human alveolar macrophage and alpha-1-antitrypsin.

Authors:  A B Cohen
Journal:  J Clin Invest       Date:  1973-11       Impact factor: 14.808

Review 6.  Pathogenesis of COPD. Part I. The role of protease-antiprotease imbalance in emphysema.

Authors:  R T Abboud; S Vimalanathan
Journal:  Int J Tuberc Lung Dis       Date:  2008-04       Impact factor: 2.373

7.  Decline in NRF2-regulated antioxidants in chronic obstructive pulmonary disease lungs due to loss of its positive regulator, DJ-1.

Authors:  Deepti Malhotra; Rajesh Thimmulappa; Ana Navas-Acien; Andrew Sandford; Mark Elliott; Anju Singh; Linan Chen; Xiaoxi Zhuang; James Hogg; Peter Pare; Rubin M Tuder; Shyam Biswal
Journal:  Am J Respir Crit Care Med       Date:  2008-06-12       Impact factor: 21.405

8.  In vivo anti-HIV activity of the heparin-activated serine protease inhibitor antithrombin III encapsulated in lymph-targeting immunoliposomes.

Authors:  Mohammed Asmal; James B Whitney; Corinne Luedemann; Angela Carville; Robert Steen; Norman L Letvin; Ralf Geiben-Lynn
Journal:  PLoS One       Date:  2012-11-02       Impact factor: 3.240

9.  Influenza HA subtypes demonstrate divergent phenotypes for cleavage activation and pH of fusion: implications for host range and adaptation.

Authors:  Summer E Galloway; Mark L Reed; Charles J Russell; David A Steinhauer
Journal:  PLoS Pathog       Date:  2013-02-14       Impact factor: 6.823

10.  Human papillomavirus infection in head and neck cancer: the role of the secretory leukocyte protease inhibitor.

Authors:  Markus Hoffmann; Elgar S Quabius; Silke Tribius; Lena Hebebrand; Tibor Görögh; Gordana Halec; Tomas Kahn; Jürgen Hedderich; Christoph Röcken; Jochen Haag; Tim Waterboer; Markus Schmitt; Anna R Giuliano; W Martin Kast
Journal:  Oncol Rep       Date:  2013-03-05       Impact factor: 3.906

View more
  21 in total

1.  Lung Injury Combined with Loss of Regulatory T Cells Leads to De Novo Lung-Restricted Autoimmunity.

Authors:  Stephen Chiu; Ramiro Fernandez; Vijay Subramanian; Haiying Sun; Malcolm M DeCamp; Daniel Kreisel; Harris Perlman; G R Scott Budinger; Thalachallour Mohanakumar; Ankit Bharat
Journal:  J Immunol       Date:  2016-05-18       Impact factor: 5.422

Review 2.  Immune Responses to Tissue-Restricted Nonmajor Histocompatibility Complex Antigens in Allograft Rejection.

Authors:  Ankit Bharat; T Mohanakumar
Journal:  J Immunol Res       Date:  2017-01-09       Impact factor: 4.818

3.  Cell-specific expression of lung disease risk-related genes in the human small airway epithelium.

Authors:  Wu-Lin Zuo; Mahboubeh R Rostami; Shushila A Shenoy; Michelle G LeBlanc; Jacqueline Salit; Yael Strulovici-Barel; Sarah L O'Beirne; Robert J Kaner; Philip L Leopold; Jason G Mezey; Juergen Schymeinsky; Karsten Quast; Sudha Visvanathan; Jay S Fine; Matthew J Thomas; Ronald G Crystal
Journal:  Respir Res       Date:  2020-07-29

4.  A novel zebrafish model to emulate lung injury by folate deficiency-induced swim bladder defectiveness and protease/antiprotease expression imbalance.

Authors:  Gang-Hui Lee; Nai-Wei Cheng; Hsin-Hsuan Yu; Jen-Ning Tsai; Tsunglin Liu; Zhi-Hong Wen; Bing-Hung Chen; Tzu-Fun Fu
Journal:  Sci Rep       Date:  2019-09-02       Impact factor: 4.379

5.  Active thrombin produced by the intestinal epithelium controls mucosal biofilms.

Authors:  Jean-Paul Motta; Alexandre Denadai-Souza; David Sagnat; Laura Guiraud; Anissa Edir; Chrystelle Bonnart; Mireille Sebbag; Perrine Rousset; Ariane Lapeyre; Carine Seguy; Noa Mathurine-Thomas; Heather J Galipeau; Delphine Bonnet; Laurent Alric; Andre G Buret; John L Wallace; Antoine Dufour; Elena F Verdu; Morley D Hollenberg; Eric Oswald; Matteo Serino; Celine Deraison; Nathalie Vergnolle
Journal:  Nat Commun       Date:  2019-07-19       Impact factor: 14.919

6.  Major Effect of Oxidative Stress on the Male, but Not Female, SP-A1 Type II Cell miRNome.

Authors:  George T Noutsios; Nithyananda Thorenoor; Xuesheng Zhang; David S Phelps; Todd M Umstead; Faryal Durrani; Joanna Floros
Journal:  Front Immunol       Date:  2019-07-10       Impact factor: 7.561

Review 7.  Alpha-1 Antitrypsin-A Target for MicroRNA-Based Therapeutic Development for Cystic Fibrosis.

Authors:  Alison M D Hunt; Arlene M A Glasgow; Hilary Humphreys; Catherine M Greene
Journal:  Int J Mol Sci       Date:  2020-01-28       Impact factor: 5.923

Review 8.  Leveraging 3D Model Systems to Understand Viral Interactions with the Respiratory Mucosa.

Authors:  Ethan Iverson; Logan Kaler; Eva L Agostino; Daniel Song; Gregg A Duncan; Margaret A Scull
Journal:  Viruses       Date:  2020-12-11       Impact factor: 5.048

9.  Lack of whey acidic protein (WAP) four-disulfide core domain protease inhibitor 2 (WFDC2) causes neonatal death from respiratory failure in mice.

Authors:  Kuniko Nakajima; Michio Ono; Uroš Radović; Selma Dizdarević; Shin-Ichi Tomizawa; Kazushige Kuroha; Go Nagamatsu; Ikue Hoshi; Risa Matsunaga; Takayuki Shirakawa; Takeyuki Kurosawa; Yasunari Miyazaki; Masahide Seki; Yutaka Suzuki; Haruhiko Koseki; Masataka Nakamura; Toshio Suda; Kazuyuki Ohbo
Journal:  Dis Model Mech       Date:  2019-11-12       Impact factor: 5.758

10.  Early nutritional supplementation in non-critically ill patients hospitalized for the 2019 novel coronavirus disease (COVID-19): Rationale and feasibility of a shared pragmatic protocol.

Authors:  Riccardo Caccialanza; Alessandro Laviano; Federica Lobascio; Elisabetta Montagna; Raffaele Bruno; Serena Ludovisi; Angelo Guido Corsico; Antonio Di Sabatino; Mirko Belliato; Monica Calvi; Isabella Iacona; Giuseppina Grugnetti; Elisa Bonadeo; Alba Muzzi; Emanuele Cereda
Journal:  Nutrition       Date:  2020-04-03       Impact factor: 4.008

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.